State of Minnesota

SENATE BILL INTRODUCTIONS

Thursday, April 11, 2019

12:00 Noon

EIGHTH ORDER OF BUSINESS

Introduction and First Reading of Senate Bills

Senator Jasinski introduced--

S.F. No. 2826: A bill for an act relating to transportation; capital investment; appropriating money for the corridors of commerce program; authorizing the sale and issuance of trunk highway bonds.

Referred to the Committee on Capital Investment.

Senator Isaacson introduced--

S.F. No. 2827: A bill for an act relating to environment; providing reimbursement to owners of private drinking water wells for mitigation of agricultural chemicals; modifying the membership of the Agricultural Chemical Response Compensation Board; appropriating money for private well mitigation; amending Minnesota Statutes 2018, sections 18E.02, subdivision 5; 18E.03, subdivision 2; 18E.05, subdivision 1; proposing coding for new law in Minnesota Statutes, chapter 18E.

Referred to the Committee on Environment and Natural Resources Policy and Legacy Finance.

Senators Ingebrigtsen, Westrom, and Senjem introduced--

S.F. No. 2828: A bill for an act relating to capital investment; appropriating money for expanding the Runestone Community Center in Alexandria; authorizing the sale and issuance of state bonds.

Referred to the Committee on Capital Investment.

Senators Abeler, Eichorn, Housley, Champion, and Goggin introduced--

S.F. No. 2829: A bill for an act relating to capital investment; appropriating money for a grant to Pillsbury United Communities.

Referred to the Committee on Jobs and Economic Growth Finance and Policy.

Senator Howe introduced--

S.F. No. 2830: A bill for an act relating to transportation; directing the Department of Transportation to develop, implement, and adhere to pavement investment guide; proposing coding for new law in Minnesota Statutes, chapter 174.

Referred to the Committee on Transportation Finance and Policy.

Senators Hoffman, Rarick, Mathews, Chamberlain, and Housley introduced--

S.F. No. 2831: A resolution memorializing the President and Congress to hold vaccine manufacturers liable for design defects that result in adverse side effects from vaccines.

Referred to the Committee on Health and Human Services Finance and Policy.